ストックスクリーナーアプリを入手
3.03
1.94%
-0.06
アフターアワーズ：
3.03
前日終値:
$3.09
開ける：
$3.12
24時間の取引高:
28,756
Relative Volume:
0.64
時価総額：
$61.09M
収益：
$264.74M
当期純損益:
$-49.71M
株価収益率:
-0.7398
EPS:
-4.0959
ネットキャッシュフロー:
$-43.55M
1週間 パフォーマンス:
-29.37%
1か月 パフォーマンス:
-32.52%
6か月 パフォーマンス:
+657.50%
1年 パフォーマンス:
+11.81%
1日の値動き範囲:
$3.01
$3.3041
1週間の範囲:
$3.01
$4.378
52週間の値動き範囲:
$0.3901
$12.30
Camp 4 Therapeutics Corp Stock (CAMP) Company Profile
名前
Camp 4 Therapeutics Corp
セクター
電話
617-651-8867
住所
ONE KENDALL SQUARE, CAMBRIDGE, CA
CAMP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CAMP
Camp 4 Therapeutics Corp
|
3.03 | 61.09M | 264.74M | -49.71M | -43.55M | -4.0959 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Camp 4 Therapeutics Corp Stock (CAMP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-05 | 開始されました | JP Morgan | Overweight |
| 2024-11-05 | 開始されました | Piper Sandler | Overweight |
| 2024-11-05 | 開始されました | William Blair | Outperform |
| 2022-08-16 | アップグレード | Craig Hallum | Hold → Buy |
| 2021-12-22 | ダウングレード | Craig Hallum | Buy → Hold |
| 2021-09-24 | 繰り返されました | Craig Hallum | Buy |
| 2021-06-25 | 繰り返されました | Craig Hallum | Buy |
| 2020-12-18 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-04-17 | アップグレード | Jefferies | Hold → Buy |
| 2020-03-05 | 繰り返されました | Craig Hallum | Buy |
| 2019-12-20 | 繰り返されました | Craig Hallum | Buy |
| 2019-12-20 | ダウングレード | First Analysis Sec | Outperform → Neutral |
| 2019-06-28 | アップグレード | Northland Capital | Market Perform → Outperform |
| 2019-05-29 | ダウングレード | Goldman | Neutral → Sell |
| 2019-05-01 | 繰り返されました | Craig Hallum | Buy |
| 2019-03-25 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2019-01-25 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-12-21 | アップグレード | Craig Hallum | Hold → Buy |
| 2018-12-14 | 繰り返されました | B. Riley FBR | Buy |
| 2018-12-11 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2018-12-11 | ダウングレード | Northland Capital | Outperform → Market Perform |
| 2018-11-27 | 開始されました | Goldman | Neutral |
| 2018-10-15 | 開始されました | Jefferies | Hold |
| 2018-09-28 | 繰り返されました | Craig Hallum | Hold |
| 2018-04-27 | 繰り返されました | Craig Hallum | Hold |
| 2018-03-08 | ダウングレード | Craig Hallum | Buy → Hold |
| 2018-02-16 | アップグレード | First Analysis Sec | Equal-Weight → Overweight |
すべてを表示
Camp 4 Therapeutics Corp (CAMP) 最新ニュース
Manasa Pamboor holds free camp for physiotherapy, speech therapy and counseling - Daijiworld
Free Camp for Physiotherapy, Speech Therapy, and Counselling at Manasa Pamboor - Mangalorean.com
CAMP4 Therapeutics Advances RNA-Based Therapeutics - TipRanks
Promising Developments and Solid Financials Support Buy Rating for CAMP4 Therapeutics - TipRanks
CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update - Yahoo Finance
Gunnison Copper Provides a Construction Update for the Johnson Camp Mine in Southeast Arizona - Yahoo Finance
CAMP4 Appoint Doug E. Williams, Ph.D., and Murray Stewart, DM FRCP To Board - citybiz
Camp4 Therapeutics expands board with two new directors By Investing.com - Investing.com Australia
Camp4 Therapeutics expands board with two new directors - Investing.com
CAMP4 Therapeutics Expands Board with New Director Appointments - TipRanks
Major Leadership Boost: CAMP4 Adds Drug Development Pioneers to Board - StockTitan
Stocks Turn Mixed as Magnificent Seven Stocks Fall - TradingView
Stocks Supported by Strength in Chip Stocks and Lower Bond Yields - TradingView
SMALL CAP IDEA: 'Flu Camp' rapid drug trial firm slashes big pharma costs - This is Money
Orchid Isle Dance Announces Connection Camp in Hawaii: Adventure Travel for the Social Dancer - Yahoo Finance
Stocks Rebound as US Government Shutdown Seems Averted - TradingView
It Might Not Be A Great Idea To Buy Camping World Holdings, Inc. (NYSE:CWH) For Its Next Dividend - Yahoo Finance
KY House passes bill to protect conversion therapy, reverse Beshear’s executive order - Lexington Herald Leader
CAMP4 Therapeutics Corporation (CAMP): Among Penny Stocks with Insider Buying in 2025 - Insider Monkey
12 Penny Stocks with Insider Buying in 2025 - Insider Monkey
Home | Department of Parks and Recreation - City and County of Honolulu (.gov)
(PDF) Combination Therapy in Pulmonary Arterial Hypertension—Targeting the Nitric Oxide and Prostacyclin Pathways - ResearchGate
RFK's plan to make America healthy again? Send people with mental health conditions to farms - Yahoo
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Fox Chase Cancer Center to Hold Fifth Annual Cancer Epigenetics Symposium - Fox Chase Cancer Center
CAMP4 to Participate in Upcoming Investor Conferences - The Manila Times
3 Key Healthcare Conferences Where CAMP4 Therapeutics Will Share Its regRNA Innovation - StockTitan
Trump to prepare facility at Guantanamo for 30,000 migrants - Reuters
Modest Final Quarter Completes Shaky Biotech IPO Comeback For 2024 - News & Insights
Top regulator calls for ban on wilderness camps in North Carolina - WBTV
CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
CAMP4 Therapeutics CEO to Present Corporate Update at J.P. Morgan Healthcare Conference - StockTitan
Here are 71 Mass. life science firms presenting at J.P. Morgan - The Business Journals
CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones - The Manila Times
Strategic Investment Boosts Exploration Plans in Ontario's Gold Camp - Streetwise Reports
Camp4 Therapeutics sees MAD safety and key biomarker data in 2H25 - TipRanks
CAMP4 Therapeutics Advances Urea Cycle Disorder Drug After $82M IPO, Secures BioMarin Partnership - StockTitan
CAMP4 Therapeutics Reports Positive Safety Data from CMP-CPS-001 Phase 1 Study and Highlights Key 2025 Milestones - Nasdaq
CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs - MSN
CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors - citybiz
CAMP4 Therapeutics Taps Former Alnylam CEO, RNA Pioneer to Drive Next-Gen Gene Therapy Platform - StockTitan
Why DocuSign Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Upstream Bio Leads Life Sciences IPOs With Upsized Listing - MSN
CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference - The Manila Times
CAMP4 Therapeutics to Present at Piper Sandler Healthcare Conference in NYC | CAMP Stock News - StockTitan
Meet the Newest Stock in the Nasdaq. It's Soared 918% Since Last Year, and It's Still a Buy Right Now, According to Certain Wall Street Analysts. - The Motley Fool
CAMP4 Reports Third Quarter 2024 Financial Results - The Manila Times
CAMP4 Therapeutics Corporation (CAMP) reports earnings - Quartz
Camp4 Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
CAMP4 Therapeutics Secures $370M BioMarin Deal, Raises $82M in IPO Milestone | CAMP Stock News - StockTitan
CalAmp Files Bankruptcy to Complete Debt Restructuring - MSN
Camp 4 Therapeutics Corp (CAMP) 財務データ
収益
当期純利益
現金流量
EPS
3.01%
大文字化:
|
ボリューム (24 時間):